ARVN
NASDAQStockArvinas, Inc.
$12.15-0.33 (-2.64%)
52-Week Range
$6.07
$13.83
Key Stats
Market Cap
780.3M
P/E Ratio
—
Dividend Yield
—
Beta
1.94
Volume
485.2K
Avg Volume
831.0K
Performance
1M
+7.12%
3M
+1.13%
6M
+63.35%
YTD
+8.81%
1Y
+43.45%
3Y
-58.09%
5Y
-82.83%
Price Chart
ETF Exposure
ARVN is held by 92 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 1.90% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.77% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.52% |
| CANC | Tema Oncology ETF | 0.39% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.38% |
| IHE | iShares U.S. Pharmaceuticals ETF | 0.23% |
| MNTL | Tema Neuroscience And Mental Health ETF | 0.15% |
| FSMO | Fidelity Small-Mid Cap Opportunities ETF | 0.14% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.13% |
| EES | WisdomTree U.S. SmallCap Fund | 0.13% |
| FSML | Franklin Small Cap Enhanced ETF | 0.12% |
| DRDR.L | iShares Healthcare Innovation UCITS ETF | 0.11% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.11% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.09% |
| 2B77.DE | iShares Ageing Population UCITS ETF | 0.08% |
| NUSC | Nuveen ESG Small-Cap | 0.08% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.07% |
| IBB | iShares Biotechnology ETF | 0.07% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.07% |
| IWN | iShares Russell 2000 Value ETF | 0.06% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.05% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.04% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.04% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.04% |
| IWM | iShares Russell 2000 ETF | 0.03% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.03% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.03% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| VTWO | Vanguard Russell 2000 ETF | 0.03% |
| RSSL | Global X - Russell 2000 ETF | 0.03% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.03% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.03% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.02% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.02% |
| XCHA.DE | Xtrackers CSI300 Swap UCITS ETF 1C | 0.02% |
| DFAS | Dimensional - US Small Cap ETF | 0.02% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.02% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.02% |
| SXRG.DE | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.02% |
| UWM | ProShares - Ultra Russell2000 | 0.02% |
| URTY | ProShares - UltraPro Russell2000 | 0.02% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.01% |
Page 1 of 2Next
About ARVN ETF Exposure
Arvinas, Inc. (ARVN) is held by 92 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 780.3M, ARVN is a widely held institutional stock. The stock currently trades at $12.15. Investors can gain exposure to ARVN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ARVN, sorted by portfolio weight.